SCHEMBL5164537

SCHEMBL5164537

N=C(N)c1cccc(NC(C(=O)Nc2ccc(N3CCCCC3=O)c(F)c2)c2cccc(F)c2)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 5/20 0.67
RAB9A P51151 4/20 0.42
ALDH1A1 P00352 3/20 0.42
NPC1 O15118 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
TP53 P04637 1/20 0.42
GLA P06280 1/20 0.42
PKM P14618 1/20 0.42
PRSS1 P07477 2/20 0.40
NPY2R P49146 1/20 0.40
MAPT P10636 2/20 0.36
KDM4E B2RXH2 1/20 0.36
POLB P06746 1/20 0.36
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
KCNQ2 O43526 1/20 0.35
TSHR P16473 1/20 0.35
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5165612 0.94 F10 (0.77) F10RAB9AALDH1A1NPC1SMN1; SMN2
SCHEMBL5164804 0.89 F10 (0.84) F10RAB9AALDH1A1NPC1SMN1; SMN2
SCHEMBL5164860 0.88 F10 (0.63) F10RAB9AALDH1A1NPC1SMN1; SMN2
SCHEMBL5164181 0.86 F10 (0.49) F10RAB9AALDH1A1NPC1SMN1; SMN2
SCHEMBL5164568 0.85 F10 (0.63) F10RAB9AALDH1A1NPC1SMN1; SMN2
SCHEMBL5164572 0.84 F10 (0.77) F10RAB9AALDH1A1NPC1SMN1; SMN2
SCHEMBL5165525 0.82 F10 (0.54) F10RAB9AALDH1A1NPC1SMN1; SMN2
SCHEMBL6808410 0.81 F10 (0.95) F10RAB9AALDH1A1NPC1SMN1; SMN2
SCHEMBL5164743 0.81 F10 (0.70) F10PRSS1NPY2RF2
SCHEMBL5165637 0.81 F10 (0.61) F10RAB9AALDH1A1NPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7273867-B2 Phenyl derivatives MERCK PATENT GMBH (DE) 2007-09-25 US claimed
EP-1351938-B1 PHENYL DERIVATIVES MERCK PATENT GMBH (DE) 2007-04-11 EP claimed
US-20040087582-A1 Phenyl derivatives MERCK PATENT GESELLSCHAFT (DE) 2004-05-06 US claimed
US-7273867-B2 Phenyl derivatives MERCK PATENT GMBH (DE) 2007-09-25 US disclosed
EP-1351938-B1 PHENYL DERIVATIVES MERCK PATENT GMBH (DE) 2007-04-11 EP disclosed
US-20040087582-A1 Phenyl derivatives MERCK PATENT GESELLSCHAFT (DE) 2004-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087582-A1 Phenyl derivatives F2, F11, SERPINC1 F10 6/4885RAB9A 2014/4885ALDH1A1 489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.